Investor |
PE Assets $mlns |
Portfolio |
M&A Activity Buy vs Sell, Last 5 Years |
|
---|---|---|---|---|
Total | Current | |||
Ampersand Capital Partners
Wellesley, Massachusetts, United States |
3,000 | 102 | 32 |
|
Sverica
Boston, Massachusetts, United States |
1,100 | 51 | 16 |
|
Frazier Healthcare Partners
Seattle, Washington, United States |
3,400 | 54 | 21 |
|
EQT Life Sciences
Amsterdam, Netherlands |
2,000 | 48 | 39 |
|
Serent Capital
San Francisco, California, United States |
1,570 | 72 | 43 |
|
Advantage Capital Partners
New Orleans, Louisiana, United States |
2,600 | 372 | 195 |
|
Merieux Equity Partners
Lyon, France |
1,465 | 22 | 16 |
|
BGF
London, United Kingdom |
3,849 | 332 | 233 |
|
EW Healthcare Partners
New York, New York, United States |
3,000 | 86 | 11 |
|
Verdane
Oslo, Norway |
1,352 | 161 | 34 |
|
Polaris Partners
Boston, Massachusetts, United States |
5,000 | 101 | 59 |
|
Fortissimo Capital
Tel Aviv, Israel |
2,700 | 52 | 32 |
|
Galen Partners
Stamford, Connecticut, United States |
1,000 | 50 | 6 |
|
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.